Keystone Financial Group Gilead Sciences, Inc. Transaction History

Keystone Financial Group

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $184,301 - $230,949	-3,182 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$64.88 - $73.64 $45,416 - $51,548	-700 Reduced 18.03%	3,182 $231,000
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $20,307 - $21,909	-300 Reduced 7.17%	3,882 $271,000
Q1 2021 May 11, 2021	SELL	$60.0 - $68.46 $2,100 - $2,396	-35 Reduced 0.83%	4,182 $270,000
Q4 2020 Feb 10, 2021	BUY	$56.65 - $64.55 $9,064 - $10,328	160 Added 3.94%	4,217 $246,000
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $36,887 - $46,379	-594 Reduced 12.77%	4,057 $256,000
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $84,493 - $98,112	-1,168 Reduced 20.07%	4,651 $358,000
Q1 2020 May 05, 2020	BUY	$62.63 - $80.22 $131,272 - $168,141	2,096 Added 56.3%	5,819 $435,000
Q4 2019 Feb 06, 2020	SELL	$61.62 - $67.78 $12,077 - $13,284	-196 Reduced 5.0%	3,723 $242,000
Q3 2019 Nov 07, 2019	BUY	$62.51 - $69.0 $22,691 - $25,047	363 Added 10.21%	3,919 $248,000
Q2 2019 Aug 07, 2019	SELL	$61.87 - $69.38 $5,568 - $6,244	-90 Reduced 2.47%	3,556 $240,000
Q1 2019 May 07, 2019	BUY	$62.53 - $70.05 $227,984 - $255,402	3,646 New	3,646 $237,000
Q4 2018 Feb 11, 2019	SELL	$60.54 - $79.0 $173,568 - $226,493	-2,867 Closed	0 $0
Q3 2018 Nov 06, 2018	BUY	$71.28 - $78.92 $204,359 - $226,263	2,867 New	2,867 $224,000
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $188,995 - $220,455	-2,913 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $21,706 - $26,462	-298 Reduced 9.28%	2,913 $213,000
Q4 2017 Feb 09, 2018	BUY	$71.15 - $83.52 $228,462 - $268,182	3,211	3,211 $239,000

1,903

1.02B

12M

9.02M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $112B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Keystone Financial Group, based on Form 13F filings with the SEC.

Stay updated on Keystone Financial Group with notifications on news.